Evidence map›Paper›PMID 42883958›Full record

ReviewInternational journal of molecular sciences2026

Dynamic Protein Adduct Formation by Methylmercury: Molecular Targets, Ligand Exchange, and Toxicological Consequences.

Takashi Toyama, Yo Shinoda, Masahiro Akiyama

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takashi ToyamaGraduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.ORCID 0000-0001-8322-3733
Yo ShinodaDepartment of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji 192-0392, Japan.ORCID 0000-0003-3253-2194
Masahiro AkiyamaDepartment of Molecular Adduct Biology, Showa Medical University Graduate School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylmercury (MeHg) is a highly toxic environmental contaminant that preferentially interacts with sulfur- and selenium-containing biomolecules. Although MeHg exposure is associated with disruption of redox homeostasis, calcium signaling, mitochondrial function, and neuronal processes, the molecular mechanisms linking MeHg chemistry to these diverse biological effects remain incompletely understood. A central feature of MeHg chemistry is its high affinity for thiol and selenol groups and its ability to undergo ligand exchange reactions with low-molecular-weight and protein thiols and selenols. Importantly, these interactions can be reversible, suggesting that MeHg toxicity may depend not only on its accumulation in cells but also on the dynamic formation and redistribution of MeHg-S and MeHg-Se adducts. In this review, we summarize the chemical basis of MeHg interactions with sulfur- and selenium-containing biomolecules, focusing on ligand exchange, reversibility, and the differential reactivity of thiols and selenols. We then discuss molecular targets of MeHg, particularly reactive cysteine and selenocysteine residues of cytosolic protein, and their potential links to cellular dysfunction and toxicity. Recent approaches for identifying MeHg-modified biomolecules, including adductomics, are also considered. Finally, we highlight unresolved questions regarding target selectivity, adduct dynamics, and the relationship between molecular modification and biological/toxicological outcomes.

Indexed as

Methylmercury CompoundsProteinsAnimalsHumansLigandsSulfhydryl CompoundsLigandsMethylmercury CompoundsProteinsSulfhydryl Compoundsligand exchangemethylmercuryprotein adductseleniumS-mercurationtoxicity

Identifiers

PMID42883958
PMCPMC13664848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.